Argan, Inc. arrives at its September 3 earnings release with a striking reversal in options sentiment — even as the stock bounces slightly after a brutal month-long selloff.
The options market has flipped in a way that deserves attention. The put/call ratio collapsed to 0.69 on September 2, more than 3.5 standard deviations below its 20-day average of 1.23. That is the most bullishly skewed reading in over a year, and it is a sharp contrast to the defensive posture that had prevailed through most of July and August, when the PCR was running above 1.5. Options traders are no longer paying up for downside protection — they are chasing calls into the print. The stock closed at $410.40 on September 2, up 1.4% on the day, but still down 28% over the past month and nearly 10% on the week.
The short-side story is broadly consistent with yesterday's note: SI as a percentage of the free float holds near 7.1%, up roughly 6.6% on the week, as bears have been rebuilding positions into the selloff rather than leading it. The borrow market offers no friction — availability is extraordinarily loose at over 2,600% of short interest, and the cost to borrow has drifted down to 0.41%, near its lowest level in months. There is no squeeze pressure, no borrow constraint, and no sign that short sellers are being forced out. They simply followed the price lower and appear comfortable holding.
The analyst picture adds its own tension. The most recent consensus data is dated — the last notable action was Lake Street raising its target to $600 in early June while staying at Hold, following a move that saw Goldman Sachs lift to $518 and JPMorgan initiate at Overweight with a $550 target back in March. Those targets now sit well above current levels. The mean analyst target of $679.80 implies roughly 66% upside from here, but that consensus reflects a stock that was trading much higher when those targets were set. Bulls can point to the power generation infrastructure buildout as a durable driver; bears would argue the 28% drawdown in a month signals either execution risk or a valuation reset that the Street has not yet fully absorbed in its published targets.
The director-level selling recorded in late July — 5,716 shares at $579.64 for proceeds of $3.3 million, without a 10b5-1 plan — is an additional data point bears can cite. That transaction happened at prices more than 40% above where the stock now trades. Among peers, LGN fell nearly 10% on the week — matching AGX's own decline — while PWR and FIX were largely flat, suggesting the weakness is not purely sector-driven.
The print will test whether the dramatic call-buying rotation into earnings reflects genuine confidence in the quarter, or simply a short-term contrarian bet on a stock that has already fallen hard.
See the live data behind this article on ORTEX.
Open AGX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
